1132662-27-1Relevant articles and documents
Efficient syntheses of 13C-labelled erythromycin biosynthetic intermediates. 2: (2S,3S,4S,5R,6R,7R)-3,6,7-trihydroxy-2,4,6-trimethyl[1- 13C]nonan-5-olide and S-2-acetylaminoethyl (2R,3S,4S,5R,6S,7R)-3,5,6, 7-tetrahydroxy-2,4,6-trimethyl [1-13C]nonanethioate
Iida, Katsumi,Kajiwara, Masahiro,Fukui, Mineo,Nakata, Tadashi,Oishi, Takeshi
, p. 218 - 225 (2008/12/20)
The 13C-labelled putative erythromycin biosynthetic intermediates, ((2S,3S,4S,5R,6R,7R)-3,6,7-trihydroxy-2,4,6-trimethyl[1- 13C]nonan-5-olide and S-2-acetylaminoethyl (2R,3S,4S,5R,6S,7R)-3,5,6, 7-tetrahydroxy-2,4,6-trimethyl[1-13C]nonanethioate), which would be useful for the investigation of the chain elongation mechanism in erythromycin biosynthesis, were efficiently synthesized via aldol condensation of aldehyde derived from (2S,3R,4R,5R)-tert-butyldimethylsilyloxy-5-3,4-O-isopropylidene-2, 4-dimethylheptanol, which was obtained in our previous work on erythromycin A synthesis, and sodium [1-13C]propionate (after conversion to ester). Copyright